Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
1.7K
TL;DR: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.
read more
Abstract: The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
TL;DR: This is the first proteogenomics study in PCa aiming at exploring a new type of metastatic factor, which are mutant peptides, predicting a novel biomarker of metastasis PCa for diagnosis, prognosis and drug targeting.
29
On chip cell separator using magnetic bead-based enrichment and depletion of various surface markers
TL;DR: An on-chip magnetic cell sorting system for the sorting of cells based on a variety of surface markers that is selective and efficient while being low cost, portable, and fabricated in a modular structure that can be integrated with other cell handling processes.
29
Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue
Immacolata Andolfo,Daniela De Martino,Lucia Liguori,Giuseppe Petrosino,Giancarlo Troncone,Nicoletta Tata,Alessia Galasso,Cristin Roma,Francesco Chiancone,Stefano Zarrilli,Gianluigi Arrigoni,Stefania Staibano,Ciro Imbimbo,Massimo Zollo +13 more
TL;DR: This retrospective survival study demonstrates that high levels of NM23-H1 expression in the cytoplasm determine recurrence of prostate-specific antigen levels only in those patients with metastatic disease, and suggests a correlation betweenHigh levels ofNM23- H1 protein in theCytoplasma of the cells and progression of prostate cancer to metastasis, thus definitively identifying NM23/H1 as a new negative prognostic marker in prostate cancer.
Expression and function of ATIP/MTUS1 in human prostate cancer cell lines.
Simon N S Louis,Laurie T C Chow,Linda Adriana Rezmann,Michael A Krezel,Kevin J. Catt,Christos Tikellis,Albert G Frauman,William J. Louis +7 more
TL;DR: This work has demonstrated Ang II type 2 (AT2‐) receptor‐mediated inhibition of EGF‐induced prostate cancer cell growth in androgen‐dependent (LNCaP) and independent (PC3) Prostate cancer cell lines.
A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene.
TL;DR: A transcriptional silencer has been identified in the 5' regulatory region of the human urokinase plasminogen activator (uPA) gene and contains an element that closely resembles the TGF-beta responsive negative element TIE.